ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

MRKR Marker Therapeutics Inc

4.11
0.06 (1.48%)
取引時間後
最終更新日: 05:00:05
15分遅延
名称 銘柄コード 市場 種別
Marker Therapeutics Inc MRKR NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.06 1.48% 4.11 05:00:05
始値 安値 高値 終値 前日終値
4.05 4.05 4.27 4.11 4.05
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0820:00GLOBEPrincipal Investigator from City of Hope National Medical..
2024/3/2606:45GLOBEMarker Therapeutics Reports Year-End 2023 Corporate and..
2024/3/2301:30GLOBEMarker Therapeutics to Present at the H.C. Wainwright 2nd..
2024/3/0122:02EDGAR2Form 8-K - Current report
2024/2/2621:58EDGAR2Form 8-K - Current report
2024/1/2221:30GLOBEMarker Therapeutics Receives Approval from United States..
2024/1/0822:30EDGAR2Form 8-K - Current report
2024/1/0822:24GLOBEMarker Therapeutics Announces Clinical Program Updates and..
2023/12/2201:00GLOBEMarker Therapeutics Announces Participation in Biotech..
2023/12/1121:35EDGAR2Form 8-K - Current report
2023/12/1121:00GLOBEMarker Therapeutics Announces Sustained Complete Response in..
2023/11/2106:37EDGAR2Form 8-K - Current report
2023/11/1007:03EDGAR2Form 8-K - Current report
2023/11/1007:00GLOBEMarker Therapeutics Reports Third Quarter 2023 Financial..
2023/11/1006:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/9/1120:10EDGAR2Form 8-K - Current report
2023/9/1120:00GLOBEMarker Therapeutics Announces Complete Response in First..
2023/8/3021:00GLOBEMarker Therapeutics to Present at the H.C. Wainwright 25th..
2023/8/1505:37EDGAR2Form 8-K - Current report
2023/8/1505:30GLOBEMarker Therapeutics Reports Second Quarter 2023 Financial..
2023/8/1505:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0720:22EDGAR2Form 8-K - Current report
2023/8/0720:00GLOBEMarker Therapeutics Reports Non-Clinical Proof-of-Concept..
2023/7/2620:00GLOBEMarker Therapeutics to Participate in Virtual Roundtable..
2023/7/1020:09EDGAR2Form 8-K - Current report
2023/7/1020:00GLOBEEuropean Medicines Agency Grants Orphan Drug Designation for..
2023/7/0605:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/7/0405:05EDGAR2Form 8-K - Current report
2023/7/0105:05EDGAR2Form 8-K - Current report
2023/6/2620:00GLOBEMarker Therapeutics Reports MT-401 Non-Clinical Data in AML..
2023/6/1220:00GLOBEMarker Therapeutics Announces First Lymphoma Patient Treated..
2023/5/3119:30GLOBEMarker Therapeutics Reports Pre-Clinical Data of its MT-601..
2023/5/0820:30GLOBEMarker Therapeutics Appoints Monic Stuart, M.D., as Chief..

最近閲覧した銘柄

Delayed Upgrade Clock